Grants

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language
Applicants can submit one application in response to the NOFO.  If more than one application is submitted by an organization, only the final application received, and time stamped by grants.gov will be reviewed for eligibility.  Each application can include multiple projects that will be evaluated independently.  

Executive Summary
Proliferator states, such as Russia and China, increasingly use the sale of their advanced conventional weapons (ACW) systems as a means to obtain financial resources, exert malign influence, and create strategic defense dependencies.  At the same time, countries with existing ACW contracts are seeing these systems operate in Ukraine, as well as experiencing the impact of manufacturing and supply shortages.  To adapt to the sanctions against them, Russia has been forced to turn to China to supply the materials, technology, and logistics for their defense industrial base for critical high priority items, creating close networks of collaboration.  

China, Russia, and other adversarial states leverage private military and security companies (PMSCs) to facilitate of the flow of weapons and ammunition, destabilize regional and national authorities, exploit natural resources including critical minerals, and harm civilian populations. The award recipient will leverage its network to conduct in-person trainings and workshops informed by open-source research on these subjects. The target audience of in-person trainings and workshops includes individuals from national and regional military and law enforcement groups as well as key policymakers of both domestic and regional groups.

Objectives include planning and organizing in-person technical events on countering proliferation of advanced conventional weapons and private military companies for at least 20-50 stakeholders per event. If more targeted sessions are necessary, ISN/CTR can consider them. The events should aim to engage participants from multiple sectors. The in-person trainings and workshops will be informed by open-source research completed in advance of trainings. 

Request Ticket // Limit: 4* (1 per grant type) // Tickets Available: 2

Legacy Researcher Grant // Limit 1 // Tickets Available: 1

Translational Research Grant // Limit: 1 // Tickets Available: 0
K. Huntoon (Neurosurgery) 

Emerging Investigator Fellowship Grant // Limit: 1 // Tickets Available: 0
S. Ganesh (Biomedical Engineering) 

Donor Designated Grant Program // Limit: 1 // Tickets Available: 1

Eligibility
Provide the name of the Institution, Principal Investigator and their title. An institution may only submit one LOI per award type. Multiple LOIs should not be submitted by the same researcher. 

Grant Categories 
The Pediatric Cancer Research Foundation awards four types of research grants: 

1. Legacy Researcher Grant (up to $100,000 per year, up to 2 years for translational research and up to $150,000 per year, for three years, for basic science research) 
   This grant is given to a long-standing PCRF-funded researcher for at least five years, who has demonstrated consistent progress and outcomes in pediatric cancer research. This funding category aims to support and sustain ongoing initiatives, ensuring that momentum is maintained on critical projects with potential for cures.  
2. Translational Research Grants (up to $100,000 per year, up to 2 years)  
   This grant is given to single or multi-institutional programs that involve open, cancer clinical trials or consortia, and implement new approaches to therapy. These grants support “bench to bedside” research, whose endpoint is often the planning or initiation of a clinical trial. 
3. Emerging Investigator Fellowship Grants (up to $75,000 for one year) 
   These grants are designed to support Post-Doctoral Fellowships and Clinical Investigator training for emerging pediatric cancer researchers to pursue exciting research ideas. Applicants must have completed two years of their fellowship or not more than two years as a junior faculty instructor or assistant professor at the start of the award period. These grants encourage and cultivate the best and brightest researchers of the future. 
4. Donor Designated Grant Programs 
   These grants fund projects in communities or regions local to the specific donor or fundraising activity. Outside contributing organizations, fundraisers and donors work with the Foundation to identify a specific project and/or specific doctor, focus on a specific disease type, facility or awareness program. Grants can be for any specific amount as designated by the donor or contributing organization. PCRF will not accept grant application without an approved Letter of Intent (LOI). Please refer to the guidelines contained in this document for the specific guidelines. 
    

Limit: 2 // Available: 0

The Breast Cancer Alliance will accept a maximum of two LOIs per institution (Exceptional Projects Grant OR Young Investigators Grant)

Exceptional Projects Grant 
K. Fischer (Gurtner Laboratory - COM-T)
C. Lim (Public Health) 

Young Investigators Grant

YOUNG INVESTIGATORS GRANT
To encourage a commitment to breast cancer research, Breast Cancer Alliance invites clinical doctors and research scientists who are in the early stages of their careers, including post docs, whose current proposal is focused on breast cancer, to apply for funding for the Young Investigator Grant.  

This grant is intended to help advance the careers of young researchers who do not yet have their own major grant support, but who design and conduct their own independent research projects. 

The term of the Young Investigator Grant is two years, beginning on March 1, 2026. The grant provides salary support and project costs for a total of a $125,000, distributed over a two-year period. 

Indirect costs, which are included in the $125,000 award, must be limited to 8% of total direct costs. 

Researchers should coordinate with their institutions, as BCA will accept a maximum of ONLY TWO LOIs PER INSTITUTION (YIG or XP.)

Qualifications 

Applicants for the 2026 award:

• Must not have held a tenure track faculty or tenure track research position for more than four years following completion of their training, as of March 1, 2026
• Must not have been or are not a principal investigator on an NIH R01 or equivalent national/international non-mentored award as of March 1, 2026
• Must dedicate at least 50% of their work effort to research
• Must be at an institution located in the contiguous United States.  
• Must not be a for-profit institution. 

EXCEPTIONAL PROJECTS GRANT 

Breast Cancer Alliance invites clinical doctors and research scientists at any stage of their careers, including post docs, whose current proposal is focused on breast cancer, to apply for an Exceptional Project Grant.  

This award recognizes creative, unique and innovative research related to breast cancer. 

The term of the Exceptional Project Grant is one year, beginning on March 1,2026. The grant provides salary support and project costs for a total of $100,000, distributed over a one-year period.  

Indirect costs, which are included in the $100,000 award, must be limited to 8% of total direct costs. 

Researchers should coordinate with their institutions, as BCA will accept a maximum of ONLY TWO LOIs PER INSTITUTION (YIG or XP).

Qualifications 

• This grant is open to applicants at institutions in the contiguous United States. 
• No for-profit institutions may apply.  

UArizona may submit 1 application.

The goals of the HSI program are to enhance the quality of undergraduate science, technology, engineering, and mathematics (STEM) education and to increase the recruitment, retention, and graduation rates of students pursuing associates or baccalaureate degrees in STEM. Achieving these, given the diverse nature and context of the HSIs, requires additional strategies that support building capacity at HSIs through innovative approaches: to incentivize institutional and community transformation; and to promote fundamental research (i) on engaged student learning, (ii) about what it takes to diversify and increase participation in STEM effectively, and (iii) that improves our understanding of how to build institutional capacity at HSIs. Intended outcomes of the HSI Program include broadening participation of students that are historically underrepresented in STEM and expanding students' pathways to continued STEM education and integration into the STEM workforce.

The HSI program is aligned with the National Science Board's vision for, and the NSF's commitment to, a more diverse and capable science and engineering workforce. HSIs are heterogeneous and unique in many respects. Some HSIs have well-established undergraduate STEM programs while others are just beginning to create STEM programs. Whether 2-year or 4-year, public or private, the HSIs serve a wide range of students with a diverse set of educational backgrounds. The need for tailored initiatives, policies, and practices (mindful of socio-cultural awareness) should meet the students' needs and institutions' expectations while advancing undergraduate students at HSIs toward higher levels of academic achievement in STEM. This is the motivation behind three HSI program tracks: Track 1: Planning or Pilot Projects (PPP); Track 2: Implementation and Evaluation Projects (IEP); and Track 3: Institutional Transformation Projects (ITP). Track 3, ITP, is motivated by work on organizational identities for HSIs that suggest that organizational culture and identity play a key role in the success of an HSI in promoting student success in STEM.

The HSI program accepts proposals in the following tracks:

- Track 1: The Planning or Pilot Projects (PPP)
- Track 2: The Implementation and Evaluation Projects (IEP)
- Track 3: The Institutional Transformation Projects (ITP)

A. Huff MacPherson

No applicants // Limit: 1 // Tickets Available: 1 

This Funding Opportunity Announcement (FOA) invites applications for Silvio O. Conte Digestive Diseases Research Core Centers (DDRCCs). The DDRCCs are part of an integrated program of digestive and liver diseases research support provided by the NIDDK. The purpose of this Centers program is to bring together basic and clinical investigators as a means to enhance communication, collaboration, and effectiveness of ongoing research related to digestive and/or liver diseases. DDRCCs are based on the core concept, whereby shared resources aimed at fostering productivity, synergy, and new research ideas among the funded investigators are supported in a cost-effective manner. Each proposed DDRCC must be organized around a central theme that reflects the focus of the digestive or liver diseases research of the Center members. The central theme must be within the primary mission of NIDDK, and not thematic areas for which other NIH Institutes or Centers are considered the primary source of NIH funding.

No applicants.

UA may submit 1 application. 

The purpose of the ASPIRE Collaborative Research Program is to facilitate translational and clinical research between NCATS intramural scientists and the extramural community to develop approaches that will enhance the ability to discover and develop new chemistries towards previously undrugged biological targets (i.e., biological targets with no known drugs to modulate their function) across many human diseases and conditions. NCATS intramural scientists have established an integrated NCATS ASPIRE platform consisting of physical and virtual modules for automated synthetic chemistry, artificial intelligence (AI) and machine learning (ML), engineering, informatics, and biological testing. The FOA will support intramural - extramural collaborations to develop additional physical modules that will enhance the platform's capabilities. The anticipated outcome includes identification, design, synthesis, and validation of new chemical entities as starting points for drug development of novel targets, and the expansion of chemical space available for drug screening.Components of Participating Organizations:National Center for Advancing Translational Sciences (NCATS)

No applicants.

UA may submit 1 application.

The Trust awards grants for distinct projects, equipment and capital needs, and, under some circumstances for general operating support and salaries. The Trust does not fund endowments or indirect costs, or make grants to individuals. In response to the pandemic, in 2020 and 2021, the Trust will consider requests for general operating support in amounts up to $10,000 from organizations whose activities normally are well-aligned with the Trust's interests. An application for general operating support may comprise the entire amount requested, or it may supplement a request for project-based funding. This policy will be in effect in both 2020 and 2021, so that organizations not eligible to apply in 2020 will have the opportunity to benefit next year.

M. McMahon

UA may submit 1 application.

Brain Research Foundation's Scientific Innovations Award Program provides funding for innovative science in both basic and clinical neuroscience. This funding mechanism is designed to support creative, exploratory, cutting-edge research in well-established research laboratories, under the direction of established investigators. The objective of the SIA is to support projects that may be too innovative and speculative for traditional funding sources but still have a high likelihood of producing important findings. It is expected that investigations supported by these grants will yield high impact findings and result in major grant applications and significant publications in high-impact journals. Funding Preferences: Funding is to be directed at projects that may be too innovative and speculative for traditional funding sources but still have a high likelihood of producing important findings. This should be a unique project for senior investigators who are encouraged to stretch their imagination into areas that can substantially change an area of research. Funding of research projects that will likely lead to successful grant applications with NIH and other public and private funding entities.

A. Gallitano

No applicants.

UA may submit 1 application.

This Funding Opportunity Announcement (FOA) solicits applications for research training activities in linked Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth). The overall objective of the GEOHealth program is to support the development of institutions in the Low- or Middle-Income Countries (LMICs) that will serve as regional hubs for collaborative research, data management, research training, curricula and outreach material development, and policy support around high priority local, national, and regional environmental and occupational health threats. These hubs are expected to conduct the research and training needed to identify and design mitigation strategies for the adverse consequences of environmental exposures and inform relevant policy development in LMICs. The global network of hubs will serve as a platform for coordinated research and research training. GEOHealth Hubs are expected to provide leadership in environmental and occupational health research and in training a new generation of environmental and occupational health experts. Hubs are supported by two coordinated linked awards to 1) a LMIC institution for research and 2) a U.S. institution for research training. Both applications must demonstrate a commitment to extensive coordination between these two awards to meet goals of the GEOHealth program. An application submitted in response to this FOA for research training must be harmonized with a linked application for related research under RFA-TW-21-001 "Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth) – Research (Collaborative U01 Clinical Trial Optional)". This research training FOA is intended to support research training of LMIC investigators, provide mentored research training opportunities in the partner LMIC, and strengthen the capacity of the partner LMIC institution to conduct environmental and occupational health research.This Funding Opportunity Announcement (FOA) allows appointment of Trainees proposing to serve as the lead investigator of an independent clinical trial; or proposing a separate ancillary clinical trial; or proposing to gain research experience in a clinical trial led by another investigator, as part of their research and career development.Components of Participating Organizations:Fogarty International Center (FIC)National Cancer Institute (NCI)National Institute on Aging (NIA)National Institute of Environmental Health Sciences (NIEHS)All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers listed above. 

No applicants.